Key Details
Price
$11.17Annual ROE
-859.11%Beta
0.85Events Calendar
Next earnings date:
Feb 26, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Aug 25, 2016Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
The consensus price target hints at a 73.4% upside potential for Alphatec (ATEC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Alphatec (ATEC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.35 per share a year ago.
24/7 Wall St. Insights With a market rotation underway, where should investors seeking opportunities in health care be looking?
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2024 Results Conference Call July 31, 2024 4:30 PM ET Company Participants Patrick Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Matt Blackman - Stifel Drew Ranieri - Morgan Stanley Aaron Wukmir - Lake Street Capital Markets David Saxon - Needham & Co. Jason Wittes - ROTH Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Second Quarter Financial Results.
Alphatec (ATEC) announces the commercial launch of its EOS Insight, an end-to-end spine surgery platform powered by standardized EOSedge scans and artificial intelligence.
Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript
Alphatec (ATEC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago.
In recent years, Alphatec Holdings has outperformed expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company is capitalizing on M&A-related disruptions at key competitors, which has created opportunities for Alphatec to grab additional market share. Persistent cash usage has resulted in substantial debt accumulation and material dilution for common shareholders, but the company appears adequately financed to reach cash flow breakeven by 2025.
Alphatec Holdings, Inc.'s focus on growth rather than improving margins raises caution for investors. Despite strong revenue growth, the company continues to experience substantial losses and slow progress on margin improvements. The recent share sales and high debt levels contribute to investor uncertainty about the company's commitment to shareholder value.
FAQ
- What is the ticker symbol for Alphatec Holdings?
- Does Alphatec Holdings pay dividends?
- What sector is Alphatec Holdings in?
- What industry is Alphatec Holdings in?
- What country is Alphatec Holdings based in?
- When did Alphatec Holdings go public?
- Is Alphatec Holdings in the S&P 500?
- Is Alphatec Holdings in the NASDAQ 100?
- Is Alphatec Holdings in the Dow Jones?
- When was Alphatec Holdings's last earnings report?
- When does Alphatec Holdings report earnings?
- Should I buy Alphatec Holdings stock now?